Jump to content

Pierre Jean Robiquet

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Lesswealth (talk | contribs) at 02:50, 28 September 2010. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pierre Robiquet
Portrait ca. 1825-1830
Born14 January 1780 (1780-01-14)
Died29 April 1840 (1840-04-30) (aged 60)
OccupationChemist

Pierre Jean Robiquet (January 13, 1780 – April 1840) was a French chemist, who laid founding work in identifying amino acids, the fundamental bricks of proteins, through recognizing the first of them, asparagin, in 1806, in the take up of the industry of industrial dyes, with the identification of alizarin in 1826, and in the emergence of modern medications, through the identification of codeine in 1832, a powerful molecule today of widespread use with analgesic and antidiarrheal properties.

Robiquet was born in Rennes. He was at first a pharmacist in the French armies during the French Revolution years and became a professor at the École de pharmacie in Paris, where he died.(for biography details refer to the fr.wikipedia article)

Notable scientific achievements were among other things his isolation and characterization of properties of asparagine (the first amino acid to be identified, from asparagus, in 1806, with Louis Nicolas Vauquelin), cantharidin (1810), the opium alkaloid narcotine (1817), caffeine (1821), alizarin (later on moved to mass industrial production by Carl Gräbe and Carl Theodore Liebermann in Germany, and by William Henry Perkin in Great Britain) and purpurin (1826), Orcin (1829), amygdalin (1830), as well as codeine (1832). Some of these discoveries were made in collaboration with other scientists. (for details on the conduct of these researches and discoveries refer to the fr.wikipedia article).

Academic titles and distinctions

Registered Pharmacist (1808), lecturer in chemistry at the Ecole Polytechnique (1811), Deputy Professor in History of pharmaceutical matters (1811) then Professor (1814) then Administrator-Treasurer (1824) at the Ecole de Pharmacie now the Faculté de Pharmacie see [3] , member then Secretary General (1817) and President (1826) of the Société de Pharmacie later on known as Académie Nationale de Pharmacie see [8], member of the Académie de Médecine (1820), member of the Académie des Sciences (1833), one of the founders and first President of the Société de Prévoyance des Pharmaciens see [6](1820).

Distinguished with the order of the Légion d'Honneur (1830).

From tinctures elaborated from vegetal or animal extracts to modern dyes industry: the pionneering work on alizarin

Even until the middle of 19th century, all dyes used for colouring cloth were natural substances, many of which were expensive and labour-intensive to extract. Furthermore, many lacked stability through washing or exposure to sunlight,or fastness.

For instance, the colour purple, which had been a mark of aristocracy and prestige since ancient times in Rome, the Middle East and Egypt, was especially expensive and difficult to produce—the dye used, known as Tyrian purple, was made from the glandular mucus of certain molluscs. Its extraction was variable and complicated,and dependent on the availability of the very specific type of shell (actually two types, now known the one as Bolinus brandaris, and the other as Hexaplex trunculus, nowadays classified within two different genders) from which it was extracted.

Another type of natural red dye used from times immemorial was obtained from madder root in Central Asia and Egypt , where it was grown as early as 1500 BC. Cloth dyed with madder root pigment was found in the tomb of the Pharaoh Tutankhamun and in the ruins of Pompeii and ancient Corinth. In the Middle Ages, Charlemagne encouraged madder cultivation. It grew well in the sandy soils of the Netherlands and became an important part of the local economy.By 1804, the English dye maker George Field had introduced new techniques known as lake madder, that extended the use of the tincture to paints.

Robiquet obtained from madder root two distinct molecules with dye properties, the one producing a magnificent red, that he called alizarin, which proved as well extremely stable, and another, of less stable properties, that he called purpurin.

Some 30 years later in April 1856, William Henry Perkin, then a mere youngster working as assistant at the Royal College of Chemistry in London within a team intent on research over the synthesis of quinine, a potent drug, discovered a process that obtained a purple dye (which he called mauveine) from aniline, which in turn could be easily obtained from coal tar; over the next ten years Perkin set up the first industrial model of molecules obtained through synthesis from coal tar and his succes had prompted intense research from numerous teams all over Europe on coal tar by-products, while he himself pursued such a work on top of his industrial activity.

Thus it came that in 1868, in turn alizarin was proved to be obtainable from anthracene, in parallel by Perkin and by Carl Gräbe and Carl Theodore Liebermann, both working in Germany for the BASF company; unfortunately Perkin missed the patent priority by one single day, alizarin's extraordinary properties made it become the first really mass industry-produced dye and enabled the rise of BASF to first rank in the chemistry industry world.

From medicines elaborated in drugstore backyards to modern pharmaceutical industry: the pionneering work on codeine

Codeine is probably Robiquet's most important contribution, that prevails still today with a very strong presence and impact on everyman's daily life; in effect, until the beginning of the 19th century, raw opium was used in diverse preparations known as laudanum (see Thomas de Quincey's "Confessions of an English Opium-Eater"), paregoric elixirs (a number of them, very popular in England since the beginning of the 18th century), and health or even death hazards to users from improper preparation or improper use were frequent.

The isolation of codeine by Robiquet from opium's several active components while working on refined morphine extraction processes, opened the path to the elaboration of a new generation of specific antitussive and antidiarrheal potions of much safer use, based on codeine only, which became immediately extremely popular.

Codeine is nowadays by far the most widely used opiate in the world and very likely even the most commonly used drug overall according to numerous reports over the years by organizations such as the World Health Organization and its League of Nations predecessor agency and others. It is one of the most effective orally-administered opioid analgesics and has a wide safety margin. It is from 8 to 12 percent of the strength of morphine in most people; differences in metabolism can change this figure as can other medications, depending on its route of administration.

While codeine can still be directly extracted from opium, its original source, most codeine is nowadays synthesized from morphine through the process of O-methylation.

Sundry Researches in pharmacology; missing by a hair's breadth the identification of the benzoyl radical in 1830

Robiquet has analysed the chemical byproducts that could be obtained from a variety of plants: asparagus, madder root, as already mentionned, with the important associated discoveries, and also others, which mostly helped in consolidating the existence of some molecules in a wide range of plants. Thus, in 1809, Robiquet extracts from liquorice root a sweetish matter which he dubs glycyrrhizine, from Glycirrhiza, the denomination of the genus to which belongs liquorice.He also obtains an oily fraction (0,8%), small quantities of a matter with properties of a gum, albuminic substances, tannins, starch, a yellowish dye, a fraction with bitter taste, and, as from asparagi, a fraction that can be crystallized and seemingly close to asparagin, which it will be indeed proven to be in 1828 by Plisson[1].

Robiquet likewise analysed a variety of animal tissues.Thus in 1810, he isolates from Lytta vesicatoria, an insect, a molecule that he calls cantharidin, which he proves is the cause of the severe irritations and blisters provoked by that insect, and is present in a variety of unrelated species that use the molecule as a protection of their eggs from predation[1] (Two families of insects belonging to the order of Coleoptera synthetise that molecule : Meloidae and Oedemeridae. The first family, to the which Lytta vesicatoria belongs in the Lytta genus, is rich of several thousands of species)

In fact, even back into the days of the early classical period civilizations of the western Mediterrean, some types of flies from Spain had a reputation for inducing aphrodisiac effects when used in preparations after having been dessicated. Cantharidin has never been proven to provide such collateral benefits, whereas Robiquet demonstrated it had very definite toxic and poisonous properties comparable in degree to that of the most violent poisons known in the XIXth century, such as strychnine[2].

This particular study, that demonstrated , as early as in 1810, the possibility to separate, using "energetic" methods, a simple "principle" that was the actual effective fraction of a traditional natural compound obtained by "soft" methods has been exemplary for the burgeonning community of chemists in the early XIXth century, and will prompt very rapidly a flurry of similar atempts that will yield within a few decades an incredible number of molecules from an ever growing number of research groups throughout Europe, and soon in the trail, in the US. In the frame of that same investigation, Robiquet in addition evidences the presence of uric acid within insects feeding on plant tissues.

Over a period of some fifteen years, Pierre Robiquet will also conduct a series of investigations on bitter almonds oil, a complex substance obtained from Prunus dulcis. In 1816, together with Jean-Jacques Colin[3], they obtain a new component which they call "éther hydrochlorique", in effect 1,2-dichloroethane, which they will try to promote as a revigorating medicine (a common pursuit in those days, as is shown by the early uses of mixture such as Coke). In 1830, together with Antoine Boutron-Charlard, Robiquet obtains a new molecule which he calls amygdalin; this component presented strange properties and was actually the first glycoside ever to be evidenced. This discovery was opening the door to the huge family of aromatic molecules, that are based on the cyclic 6 carbon benzenoic structure. In their various attempts at breaking down amygdalin in by-products, Robiquet and Boutron-Charlard obtained benzaldehyd but they failed in working out a proper interpretation of the structure of amygdalin that would account for it, and thus missed the identification of the benzoyl radical C7H5O. This last step was achieved some few months later (1832) by Friedrich Wöhler and Justus Liebig, these two got somehow a bit unfairly all the credit for this breakthrough result that was opening a entirely new branch for the industry of chemicals with wide ranging applications.

Amygdalin and related variant molecules have been used throughout the XIXth (under promotion e.g. by Ernst T. Krebs) and XXth centuries as anti-cancer drugs, however with unconclusive results as to actual benefits, while it was demonstrated in 1972 in a study at the Sloan-Kettering Cancer Institute that amygdalin and a related product that was commercialized under the name of "laetrile" actually could produce occasionnally poisoning symptoms in some patients, due to degradation "in corpore" that produced cyanide.

Bibliography

  • "Pierre Jean Robiquet", in Louis-Gabriel Michaud, old and modern universal Biography: history alphabetically of the public and private life of all the men with the collaboration of more than 300 scientists and literary men French or foreign, 2e edition, 1843–1865
  • C. Warolin, Rev Hist Pharm (Paris). 1999;47(321):97-110. PMID 11625518
  • Pierre Jean Robiquet (1780–1840), dans "Figures pharmaceutiques françaises", 3 p, de Pierre Crété.
  • A. Bussy. Eloge de Pierre Robiquet. J. pharm., avril 1841 (Obituary)

Main published works

  • 1805 : Essai analytique des asperges Annales de chimie, 55 (1805), 152–171
  • 1806 : La découverte d'un nouveau principe végétal dans le suc des asperges L.N.Vauquelin et P.J.Robiquet, Annales de Chimie, 57, p88–93.
  • 1810 : Expériences sur les cantharides, Robiquet, Annales de Chimie, 1810, vol. 76, pp. 302–322.
  • 1812 : Observations sur la nature du kermès, Robiquet, Annales de Chimie, 81 (1812), 317–331.
  • 1816 : Recherches sur la nature de la matière huileuse des chimistes hollandais, Robiquet, Colin, Annales de Chimie et de Physique, 1816, vol. 1, pp. 337–45.
  • 1817 : Observations sur le memoire de M. Sertuerner relatif à l’analyse de l’opium, Robiquet, Annales de Chimie et de Physique ,5 (1817), 275–278;
  • 1822 : Nouvelles experiences sur l’huile volatile d’amandes ameres, Robiquet, Annales de Chimie et de Physique , 21 (1822), 250–255.
  • 1826 : De l'emploi du bicarbonate de soude dans le traitement médical des calculs urinaires
  • 1826 : Sur un nouveau principe immédiat des végétaux (l’alizarine) obtenu de la garance Robiquet, Colin ,Journal de pharmacie et des sciences accessoires, 12 (1826), 407–412
  • 1827 : Nouvelles recherches sur la matière colorante de la garance, Robiquet, Colin, Annales de chimie et de physique, 34 (1827), 225–253
  • 1829 : Essai analytique des lichens de l’orseille, Robiquet, Annales de chimie et de physique, 42 (1829), 236–257
  • 1830 : Nouvelles expériences sur les amandes amères et sur l'huile volatile qu'elles fournissent Robiquet, Boutron-Charlard, Annales de chimie et de physique, 44 (1830), 352–382
  • 1831 : Nouvelles expériences sur la semence de moutarde
  • 1832 : Nouvelles observations sur les principaux produits de l’opium, P.J.Robiquet, Annales de chimie et de physique, 51 (1832), 225–267
  • 1832 : Notice historique sur André Laugier (suivie d'une autre notice sur Auguste-Arthur Plisson)

Notes and references

  1. ^ http:///www.ibiblio.org/herbmed/eclectic/kings/glycyrrhiza.html
  2. ^ Robiquet. M., Ann. Chim., 1810, vol. 76, pp. 302-307.
  3. ^ "Recherches sur la nature de la matière huileuse des chimistes hollandais., Annal Chim Phys, 1816, vol. 1, pp.337-45.
  • [1]Baumann E (1884). "Über cystin und cystein". Z Physiol Chemie 8: 299.
  • [2]Braconnot HM (1820). "Sur la conversion des matières animales en nouvelles substances par le moyen de l'acide sulfurique". Ann Chim Phys Ser 2 13: 113–25.
  • Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH (February 1981). "A pharmacologic and toxicological study of amygdalin". JAMA 245 (6): 591–4. doi:10.1001/jama.245.6.591. PMID 7005480.
  • Moertel CG, Fleming TR, Rubin J (January 1982). "A clinical trial of amygdalin (Laetrile) in the treatment of human cancer". N. Engl. J. Med. 306 (4): 201–6. doi:10.1007/s00520-006-0168-9. PMID 7033783. http://content.nejm.org/cgi/content/abstract/306/4/201.

Associated articles

Curiosity items about Pierre Robiquet at today's "École de Pharmacie" in Paris

The "Ecole de Pharmacie", nowadays the "Faculté de Pharmacie" (University of pharmaceutical sciences) of Paris , stands 4, avenue de l'Observatoire, Paris 5eme

  • portrait by Devouge, Salle des Actes; visit http://www.shp-asso.org/index.php?PAGE=salledesactes and go to portrait n°48
  • One of the many figure head medallions that adorn the walls of the inner court of the building represents Pierre Robiquet (along with other famed pharmacists and chemists such as Chaptal, Houel, Fourcroy, Antoine de Jussieu, Caventou et Pelletier, Brongniart, Newton, Lavoisier, Berthollet, Dumas, Bernard...) (visit [3] Société d'Histoire de la Pharmacie and [4] Les médaillons de la Faculté de Pharmacie de Paris)
  • [5] Origines de la "Société de Prévoyance des Pharmaciens"
  • [6] La codéine : Pierre ROBIQUET (1780–1840)
  • [cat.inist.fr/?aModele=afficheN&cpsidt=15271599] La Création de l'Ecole de Pharmacie
  • [7] Académie Nationale de Pharmacie